CDK2 and neoplasm: Our findings indicate that Cdk2-/- tumor cells combined anthracyclines trigger a more robust series of immunostimulatory stress pathways than WT cells, including apoptosis stress, endoplasmic reticulum stress, HMGB1 release, and type-1 interferon response, stimulate DCs and T cells infiltration.